Efficacy and safety of denosumab for the treatment of osteoporosis in patients with renal failure
Not Applicable
- Conditions
- Osteoporosis
- Registration Number
- JPRN-UMIN000011992
- Lead Sponsor
- ephrology Center, Toranomon Hospital Nephrology Center, Toranomon Hospital Kajigaya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
CKD patients with corrected calcium (cCa)<8.5 mg/dl or serum PTH> 110 pg/ml. Patients with dialysis whose serum Ca, P, and PTH are out of the range recommended by JSDT 2012 (cCa 8.5-10.0 mg/dl, P 3.5-6.0 mg/dl, and PTH 60-240 pg/ml)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method